chr10-98392430-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP3
The NM_032709.3(PYROXD2):c.1062+2T>G variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000818 in 1,612,848 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032709.3 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PYROXD2 | NM_032709.3 | c.1062+2T>G | splice_donor_variant | ENST00000370575.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PYROXD2 | ENST00000370575.5 | c.1062+2T>G | splice_donor_variant | 1 | NM_032709.3 | P1 | |||
PYROXD2 | ENST00000483923.5 | n.1964+2T>G | splice_donor_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000856 AC: 13AN: 151826Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000878 AC: 22AN: 250546Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135460
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461022Hom.: 1 Cov.: 31 AF XY: 0.0000853 AC XY: 62AN XY: 726886
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151826Hom.: 0 Cov.: 32 AF XY: 0.0000944 AC XY: 7AN XY: 74156
ClinVar
Submissions by phenotype
Leigh syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The homozygous c.1062+2T>G variant in PYROXD2 was identified by our study in 2 siblings with cerebral cortical atrophy, bilateral tonic-clonic seizure, and global developmental delay. The c.1062+2T>G variant in PYROXD2 has not been previously reported in individuals with neurological disease, but has been identified in 0.015% (10/67942) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs199640378). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. This variant is located in the 5' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. It is of note that loss of function of PYROXD2 in an autosomal recessive disease has not yet been established based on the criteria laid out in Abou-Tayoun, 2018 (PMID: 30192042). In summary, the clinical significance of the c.1062+2T>G variant is uncertain. ACMG/AMP Criteria applied: PM3_Supporting (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at